Gao Jianpeng, Zhao Zhenxiong, Pan Hongda, Huang Yakai
Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Transl Cancer Res. 2024 Jun 30;13(6):2674-2690. doi: 10.21037/tcr-24-124. Epub 2024 Jun 20.
Prognosis of gastric cancer (GC) patients with ovarian metastasis (OM) remains poor. We hereby characterized the role of tumor immune microenvironment (TIME) and identified potential key regulators in the OM with the aim of understanding its molecular basis to develop novel therapeutic targets.
Transcriptomic analyses of paired primary and ovarian metastatic lesions of seven GC patients from Fudan University Shanghai Cancer Center uncovered and functionally annotated their differentially expressed genes (DEGs). CIBERSORT analysis revealed differential TIME between primary GCs and OMs, which was further validated by multiplex immunofluorescence (mIF). Unique overexpression of candidate regulator in OMs was validated by an immunohistochemical (IHC) staining-based cohort study and cell growth, migration and invasion assays were conducted to characterize its function in GC progression.
Functional enrichment analyses of DEGs between GCs and matched OMs revealed multiple significantly dysregulated immune-related and cancer-related pathways. Distinctive subsets of immune cells, especially M2 macrophage, were selectively enriched in metastatic lesions. mIF-based quantification further validated the overexpression of CD68CD206 M2 macrophage in the OMs. Estrogen receptor 2 (), which encodes estrogen receptor β (ERβ), was not only potentially correlated with M2 macrophage but also overexpressed in the OM of GC. was up-regulated in cancerous tissue and its high expression correlated with younger age, more advanced lymph node metastasis and pathological stage, as well as a worse patient survival. IHC staining of ERβ in the cohort of paired primary and metastatic GCs validated its selective overexpression in OMs. Small-interfering RNAs (siRNAs)-induced knockdown of significantly inhibited the invasion and migration of both AGS and HGC-27 GC cell lines.
Comparative RNA-sequencing analysis revealed the dysregulated TIME, M2 macrophage in particular, between primary GC and OM. potentially correlated with M2 macrophage and played pro-oncogenic roles in GC progression and metastasis.
发生卵巢转移(OM)的胃癌(GC)患者预后仍然很差。我们在此表征肿瘤免疫微环境(TIME)的作用,并确定OM中的潜在关键调节因子,以了解其分子基础,从而开发新的治疗靶点。
对来自复旦大学附属肿瘤医院的7例GC患者的原发性和卵巢转移病灶进行转录组分析,发现并对其差异表达基因(DEG)进行功能注释。CIBERSORT分析揭示了原发性GC和OM之间不同的TIME,通过多重免疫荧光(mIF)进一步验证。通过基于免疫组织化学(IHC)染色的队列研究验证OM中候选调节因子的独特过表达,并进行细胞生长、迁移和侵袭试验以表征其在GC进展中的功能。
GC与匹配的OM之间DEG的功能富集分析揭示了多个显著失调的免疫相关和癌症相关途径。免疫细胞的独特亚群,尤其是M2巨噬细胞,在转移病灶中选择性富集。基于mIF的定量进一步验证了OM中CD68⁺CD206⁺ M2巨噬细胞的过表达。编码雌激素受体β(ERβ)的雌激素受体2(ESR2)不仅可能与M2巨噬细胞相关,而且在GC的OM中过表达。ESR2在癌组织中上调,其高表达与年龄较小、淋巴结转移和病理分期更晚以及患者生存率更差相关。配对原发性和转移性GC队列中ERβ的IHC染色验证了其在OM中的选择性过表达。小干扰RNA(siRNA)诱导的ESR2敲低显著抑制了AGS和HGC-27 GC细胞系的侵袭和迁移。
比较RNA测序分析揭示了原发性GC和OM之间失调的TIME,特别是M2巨噬细胞。ESR2可能与M2巨噬细胞相关,并在GC进展和转移中发挥促癌作用。